Acquiring Company
RCP
Acquired Company
Angelini Pharma
Tucson
RomeManufacturingHealth CareMedicalBiotechnologyHealth CarePharmaceuticalDescription
RCP has announced the acquisition of the Peracidin product line from Angelini Pharma. This move aims to enhance RCP's portfolio in dialysis products and related applications. The acquisition supports RCP's growth and commitment to quality customer service. CEO Vern Taaffe highlighted the strategic importance of this deal for their expansion.
Don't miss RCP's next move
Get an email the moment RCP makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Angelini Pharma?
Angelini Pharma was acquired by RCP, based in Tucson. The deal was reported on September 4, 2026. RCP develops, manufactures, and supplies dialysis products. The company provides technical expertise and specialized solutions for healthcare providers. RCP is privately held and operates in Manufacturing.
When did RCP acquire Angelini Pharma?
RCP's acquisition of Angelini Pharma was reported on September 4, 2026. RCP has announced the acquisition of the Peracidin product line from Angelini Pharma. This move aims to enhance RCP's portfolio in dialysis products and related applications. The acquisition supports RCP's growth and commitment to quality customer service. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Angelini Pharma do?
Angelini Pharma is part of the privately owned Angelini Industries and is an emerging leader in brain health. It is privately held, operating in Biotechnology, and is based in Rome.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.